http://www.pharmabioingredients.com Thu, 05 Mar 2009 08:14:41 -0500 FeedCreator 1.7.2 http://feedproxy.google.com/~r/PharmaBioIngredientsBreakingNews/~3/Pe0-cFG4GJI/battle_for_hiv_drug_market_share_getting_fiercer_ The HIV market, worth $9.3 billion in 2007, is expected to grow to $15.1 billion by 2017, driven by the increasing prevalence of HIV worldwide and the longer life expectancy of patients receiving trea... Luke Glasner Wed, 24 Sep 2008 15:46:00 -0500 http://www.pharmabioingredients.com/news/2008/09/24/battle_for_hiv_drug_market_share_getting_fiercer_ http://feedproxy.google.com/~r/PharmaBioIngredientsBreakingNews/~3/RlSt2Jo1T-I/is_an_rx-to-otc_move_the_right_prescription_to_protect_pharma_revenues_%2526_cut_healthcare_costs%3f_ With the growing cost of developing novel drugs combined with the fact that from year-to-year fewer such drugs are gaining regulatory approval, the use by pharmaceutical companies of lifecycle managem... Luke Glasner Fri, 12 Sep 2008 08:44:00 -0500 http://www.pharmabioingredients.com/news/2008/09/12/is_an_rx-to-otc_move_the_right_prescription_to_protect_pharma_revenues_%2526_cut_healthcare_costs%3f_ http://feedproxy.google.com/~r/PharmaBioIngredientsBreakingNews/~3/8YlzZO8eeRM/is_cost_containment_impacting_pharmaceutical_innovation%3f With the costs of providing healthcare spiraling, governments and payers across the seven major markets are implementing cost-cutting initiatives in an effort to combat these escalating healthcare cos... Luke Glasner Thu, 04 Sep 2008 16:42:00 -0500 http://www.pharmabioingredients.com/news/2008/09/04/is_cost_containment_impacting_pharmaceutical_innovation%3f http://feedproxy.google.com/~r/PharmaBioIngredientsBreakingNews/~3/qJiwHXUG9Vk/monoclonal_antibody_sales_to_almost_double_in_coming_years_ In 2007 total global monoclonal antibody (mAb) sales reached $26 billion and are forecast to almost double to $49 billion by 2013. While small molecule drug sales will continue to make up the majority... Luke Glasner Thu, 28 Aug 2008 16:40:00 -0500 http://www.pharmabioingredients.com/news/2008/08/28/monoclonal_antibody_sales_to_almost_double_in_coming_years_ http://feedproxy.google.com/~r/PharmaBioIngredientsBreakingNews/~3/ahRgnv8NLAM/phrma_revised_marketing_code_reinforces_commitment Reflecting the continuing commitment of America’s pharmaceutical research and biotechnology companies to pursue policies and practices that best serve the needs of patients and the healthcare co... Luke Glasner Fri, 11 Jul 2008 13:05:00 -0500 http://www.pharmabioingredients.com/news/2008/07/11/phrma_revised_marketing_code_reinforces_commitment http://feedproxy.google.com/~r/PharmaBioIngredientsBreakingNews/~3/Ed5rih1RD8Q/pfizer%27s_plan_to_sell_little_island_api_plant_falters A deal to sell Pfizer's active pharmaceutical ingredient manufacturing (API) plant in County Cork, Ireland, has fallen through according to a statement by the US drug giant, placing over 180 producti... Luke Glasner Fri, 11 Jul 2008 08:42:00 -0500 http://www.pharmabioingredients.com/news/2008/07/11/pfizer%27s_plan_to_sell_little_island_api_plant_falters http://feedproxy.google.com/~r/PharmaBioIngredientsBreakingNews/~3/2tSLe6J_POI/scinopharm_passes_japanese_pmda_gmp_inspection ScinoPharm Taiwan, a leading active pharmaceutical ingredient (API) supplier to the global pharmaceutical and biotechnology industry, announced it has successfully passed a GMP inspection by Japan&rsq... Luke Glasner Fri, 11 Jul 2008 08:28:00 -0500 http://www.pharmabioingredients.com/news/2008/07/11/scinopharm_passes_japanese_pmda_gmp_inspection http://feedproxy.google.com/~r/PharmaBioIngredientsBreakingNews/~3/4V8XUnC8vm0/dow_acquires_rohm_and_haas%2c_creating_world%92s_leading_specialty_chemicals_and_advanced_materials_company Dow (NYSE: DOW) and Rohm and Haas (NYSE: ROH) today announced a definitive agreement, under which Dow will acquire all outstanding shares of Rohm and Haas common stock for $78 per share in cash. ... Luke Glasner Thu, 10 Jul 2008 15:31:00 -0500 http://www.pharmabioingredients.com/news/2008/07/10/dow_acquires_rohm_and_haas%2c_creating_world%92s_leading_specialty_chemicals_and_advanced_materials_company http://feedproxy.google.com/~r/PharmaBioIngredientsBreakingNews/~3/95wlmW0nvCw/americhem_offers_expanded_line_of_color_solutions_to_the_pharmaceutical_packaging Americhem Inc., a global supplier of custom color and additive solutions for polymer-based products, has long been a leading provider of color masterbatches for pharmaceutical applications. In fact, A... Luke Glasner Thu, 10 Jul 2008 08:18:00 -0500 http://www.pharmabioingredients.com/news/2008/07/10/americhem_offers_expanded_line_of_color_solutions_to_the_pharmaceutical_packaging http://feedproxy.google.com/~r/PharmaBioIngredientsBreakingNews/~3/TkLGseHXsVQ/lilly_buying_out_sgx_pharmaceuticals Lilly has signed a definitive merger agreement to acquire SGX Pharmaceuticals, Inc. for approximately $64 million in cash. SGX, based in San Diego, CA, is a biotechnology company focused on oncology d... Luke Glasner Wed, 09 Jul 2008 16:02:00 -0500 http://www.pharmabioingredients.com/news/2008/07/09/lilly_buying_out_sgx_pharmaceuticals http://feedproxy.google.com/~r/PharmaBioIngredientsBreakingNews/~3/gMT05v_Sj8A/thomson_reuters_introduces_a_new_solution_to_boost_competitive_advantage_in_china%27s_generics_and_api_market Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced at CPhI China 2008(1) the release of Newport Horizon Premium, designed specific... Luke Glasner Tue, 01 Jul 2008 08:15:00 -0500 http://www.pharmabioingredients.com/news/2008/07/01/thomson_reuters_introduces_a_new_solution_to_boost_competitive_advantage_in_china%27s_generics_and_api_market http://feedproxy.google.com/~r/PharmaBioIngredientsBreakingNews/~3/sdQoLVhZesk/barr_announces_favorable_ruling_in_mirapex%28r%29_patent_challenge Barr Pharmaceuticals, Inc. today announced that U.S. District Court for Delaware has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Boehringer Inge... Luke Glasner Fri, 27 Jun 2008 09:11:00 -0500 http://www.pharmabioingredients.com/news/2008/06/27/barr_announces_favorable_ruling_in_mirapex%28r%29_patent_challenge http://feedproxy.google.com/~r/PharmaBioIngredientsBreakingNews/~3/ugaDHXTaMLA/api_inspection_company_blue_inspection_body_appoints_prof._dr._werner_fresenius_to_its_advisory_board_m%fcnster_%28germany%29%2c_26_june_2008. Audit service provider blue inspection body GmbH (www.blue-inspection.com) has appointed Prof. Dr. Werner Fresenius, for many years head of medicinal product surveillance in Rheinland-Pfalz, Germany, ... Luke Glasner Fri, 27 Jun 2008 08:49:00 -0500 http://www.pharmabioingredients.com/news/2008/06/27/api_inspection_company_blue_inspection_body_appoints_prof._dr._werner_fresenius_to_its_advisory_board_m%fcnster_%28germany%29%2c_26_june_2008. http://feedproxy.google.com/~r/PharmaBioIngredientsBreakingNews/~3/4tkC-KdczHo/barr_labs_has_enters_into_supply_and_licensing_agreements_with_bayer Barr Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, Barr Laboratories, Inc. has entered into supply and licensing agreements with Bayer for generic versions of Bayer's Yasmin(... Luke Glasner Tue, 24 Jun 2008 13:16:00 -0500 http://www.pharmabioingredients.com/news/2008/06/24/barr_labs_has_enters_into_supply_and_licensing_agreements_with_bayer http://feedproxy.google.com/~r/PharmaBioIngredientsBreakingNews/~3/ezOQ2RgRfjE/kendle_experts_to_cover_several_topics_at_tradeshow Kendle, a leading global full-service clinical research organization (CRO), today announced that several of its experts will present at the upcoming Drug Information Association (DIA) 44th Annual Meet... Luke Glasner Thu, 19 Jun 2008 16:45:00 -0500 http://www.pharmabioingredients.com/news/2008/06/19/kendle_experts_to_cover_several_topics_at_tradeshow